Cargando…
Efficacy and safety of cinacalcet compared with other treatments for secondary hyperparathyroidism in patients with chronic kidney disease or end-stage renal disease: a meta-analysis
BACKGROUND: It is controversial for the effect and safety between cinacalcet and other treatments in treating secondary hyperparathyroidism for patients with chronic kidney disease (CKD) or end-stage renal disease (ESRD). METHODS: Embase, PubMed, and Cochrane Library were searched through Feb 2017....
Autores principales: | Sun, Yiting, Tian, Binyao, Sheng, Zitong, Wan, Pengzhi, Xu, Tianhua, Yao, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7393724/ https://www.ncbi.nlm.nih.gov/pubmed/32736534 http://dx.doi.org/10.1186/s12882-019-1639-9 |
Ejemplares similares
-
Effectiveness of Cinacalcet in Patients with Chronic Kidney Disease and Secondary Hyperparathyroidism Not Receiving Dialysis
por: Pérez-Ricart, Ariadna, et al.
Publicado: (2016) -
Paricalcitol vs. cinacalcet for secondary hyperparathyroidism in chronic kidney disease: A meta-analysis
por: Xu, Wei, et al.
Publicado: (2020) -
Management of pre-renal transplant secondary hyperparathyroidism: parathyroidectomy versus cinacalcet
por: Elhadedy, Muhammed Ahmed, et al.
Publicado: (2023) -
Long-term effectiveness of cinacalcet in non-dialysis patients with chronic kidney disease and secondary hyperparathyroidism
por: Pérez-Ricart, Ariadna, et al.
Publicado: (2019) -
Cost-effectiveness analysis of cinacalcet vs. paricalcitol in the
treatment of hyperparathyroidism secondary to chronic kidney
disease
por: Ponce, Daniela, et al.
Publicado: (2023)